Crinetics Pharmaceuticals (CRNX) Long-Term Deferred Tax (2024)
Crinetics Pharmaceuticals' (CRNX) quarterly Long-Term Deferred Tax came in at $291.5 million in Q4 2024.
Crinetics Pharmaceuticals (CRNX) Long-Term Deferred Tax (2024) Analysis & Trends
Crinetics Pharmaceuticals' Long-Term Deferred Tax history runs 1 years deep, the most recent figure standing at $291.5 million for Q4 2024.
- On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $291.5 million in Q4 2024; TTM through Dec 2024 was $291.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $291.5 million, changed N/A from the prior year.
- Long-Term Deferred Tax steadied at $291.5 million in Q4 2024 per CRNX's latest filing.
- Across five years, Long-Term Deferred Tax topped out at $291.5 million in Q4 2024 and bottomed at $291.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.71 Bn | 7.42 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 291.54 Mn |